CD4 and glioblastoma: The RNA transcriptome revealed substantial differences between CD4+ T cells from tumor and blood of GBM patients in their RNA expression pattern: 341 genes with log2 fold change of 2 or more and p value < 0.01 were shown to be dysregulated in these cells in GBM relative to their expression in blood.